Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study

• Principais autores: Haiyan Guo (Autor), Jinrong Fu (Autor), Yufeng Zhou (Autor), Feihong Luo (Autor), Ruoqian Cheng (Autor)
• Formato: Livro
• Publicado em: BMC, 2024-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Recombinant human growth hormone (rhGH) therapy is beneficial for children with Prader-Willi syndrome (PWS) in improving short stature and metabolism, but the effect of early rhGH treatment on respiratory and sleep parameters for PWS children under three years old remains elusive...